MEP39708A - New pharmaceutical compositions containing epinastine and pseudoephedrine - Google Patents

New pharmaceutical compositions containing epinastine and pseudoephedrine

Info

Publication number
MEP39708A
MEP39708A MEP-397/08A MEP39708A MEP39708A ME P39708 A MEP39708 A ME P39708A ME P39708 A MEP39708 A ME P39708A ME P39708 A MEP39708 A ME P39708A
Authority
ME
Montenegro
Prior art keywords
pseudoephedrine
pharmaceutical compositions
compositions containing
pharmaceutically acceptable
new pharmaceutical
Prior art date
Application number
MEP-397/08A
Other languages
Bosnian (bs)
English (en)
Inventor
Sara Abelaira
Daniel Bianchi
Francisco Gel
Victor Denker
Mabel Fernandez
Marta Cicconi De Vidal
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8170029&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MEP39708(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of MEP39708A publication Critical patent/MEP39708A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/08—Antibacterial agents for leprosy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Otolaryngology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MEP-397/08A 2000-10-06 2001-09-28 New pharmaceutical compositions containing epinastine and pseudoephedrine MEP39708A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP00121828 2000-10-06
PCT/EP2001/011229 WO2002028373A1 (en) 2000-10-06 2001-09-28 New pharmaceutical compositions containing epinastine and pseudoephedrine
YU24603A YU24603A (sh) 2000-10-06 2001-09-28 Novi farmaceutski preparati koji sadrže epinastin i pseudoefedrin

Publications (1)

Publication Number Publication Date
MEP39708A true MEP39708A (en) 2011-02-10

Family

ID=8170029

Family Applications (1)

Application Number Title Priority Date Filing Date
MEP-397/08A MEP39708A (en) 2000-10-06 2001-09-28 New pharmaceutical compositions containing epinastine and pseudoephedrine

Country Status (32)

Country Link
EP (1) EP1326586B1 (ko)
JP (1) JP2004521864A (ko)
KR (1) KR20030036894A (ko)
CN (1) CN1291715C (ko)
AR (2) AR032479A1 (ko)
AT (1) ATE424813T1 (ko)
AU (2) AU1229002A (ko)
BG (1) BG107686A (ko)
BR (1) BR0114339A (ko)
CA (1) CA2423288C (ko)
CZ (1) CZ2003945A3 (ko)
DE (1) DE60137952D1 (ko)
EA (1) EA007288B1 (ko)
EC (1) ECSP034513A (ko)
EE (1) EE200300138A (ko)
ES (1) ES2323570T3 (ko)
HK (1) HK1062196A1 (ko)
HR (1) HRP20030259A2 (ko)
HU (1) HUP0300970A3 (ko)
IL (1) IL154884A0 (ko)
ME (1) MEP39708A (ko)
MX (1) MXPA03002900A (ko)
MY (1) MY131159A (ko)
NO (1) NO20031537L (ko)
NZ (1) NZ525653A (ko)
PE (1) PE20020324A1 (ko)
PL (1) PL366123A1 (ko)
SK (1) SK4052003A3 (ko)
UA (1) UA75896C2 (ko)
WO (1) WO2002028373A1 (ko)
YU (1) YU24603A (ko)
ZA (1) ZA200302079B (ko)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003000264A1 (en) * 2001-06-20 2003-01-03 Schering Corporation Antihistamines for the treatment of nasal congestion and nasal obstruction
JP4549618B2 (ja) * 2001-11-22 2010-09-22 第一三共ヘルスケア株式会社 鼻炎用組成物
WO2004014353A1 (en) * 2002-08-02 2004-02-19 Boehringer Ingelheim International Gmbh Pharmaceutical formulations comprising combinations of epinastine, pseudoephedrine and methylephedrine
JP5021155B2 (ja) * 2003-08-01 2012-09-05 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング エピナスチンと１種以上のさらなる抗−ｈ１−ヒスタミン類との組合せを含む皮膚疾患治療用製薬組成物
WO2005079752A2 (en) * 2004-02-11 2005-09-01 Rubicon Research Private Limited Controlled release pharmaceutical compositions with improved bioavailability

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0903151A1 (en) * 1997-09-22 1999-03-24 ASTA Medica Aktiengesellschaft Use of combinations comprising non-sedating antihistamines and alpha-adrenergic drugs for the topical treatment of rhinitis/conjunctivitis and cold, cold-like and/or flu symptoms
ID26390A (id) * 1997-12-23 2000-12-21 Schering Corp Komposisi untuk pengobatan pernapasan dan penyakit kulit sekurangnya terdiri dari satu leukotrien antagonis dan satu antihistamin
EP1117405A2 (en) * 1998-10-09 2001-07-25 Schering Corporation Composition and method for treating allergic diseases
US6613357B2 (en) * 2000-01-13 2003-09-02 Osmotica Corp. Osmotic device containing pseudoephedrine and an H1 antagonist

Also Published As

Publication number Publication date
NO20031537L (no) 2003-06-04
MY131159A (en) 2007-07-31
UA75896C2 (en) 2006-06-15
HUP0300970A3 (en) 2005-03-29
EP1326586B1 (en) 2009-03-11
MXPA03002900A (es) 2003-09-10
ZA200302079B (en) 2004-05-05
ECSP034513A (es) 2003-04-25
EA007288B1 (ru) 2006-08-25
NZ525653A (en) 2006-07-28
PE20020324A1 (es) 2002-06-18
KR20030036894A (ko) 2003-05-09
EE200300138A (et) 2003-08-15
AR087240A2 (es) 2014-03-12
CA2423288C (en) 2007-11-13
CN1291715C (zh) 2006-12-27
PL366123A1 (en) 2005-01-24
DE60137952D1 (de) 2009-04-23
AU2002212290B2 (en) 2006-08-03
ATE424813T1 (de) 2009-03-15
HRP20030259A2 (en) 2005-02-28
WO2002028373A1 (en) 2002-04-11
SK4052003A3 (en) 2003-09-11
BG107686A (bg) 2003-11-28
EA200300430A1 (ru) 2003-10-30
YU24603A (sh) 2006-05-25
IL154884A0 (en) 2003-10-31
AR032479A1 (es) 2003-11-12
HUP0300970A2 (hu) 2003-11-28
AU1229002A (en) 2002-04-15
HK1062196A1 (en) 2004-10-21
NO20031537D0 (no) 2003-04-04
BR0114339A (pt) 2003-12-09
EP1326586A1 (en) 2003-07-16
CN1468094A (zh) 2004-01-14
ES2323570T3 (es) 2009-07-21
CZ2003945A3 (cs) 2003-08-13
CA2423288A1 (en) 2002-04-11
JP2004521864A (ja) 2004-07-22

Similar Documents

Publication Publication Date Title
DE60126980D1 (de) Therapeutische agentien und methoden ihrer verwendung zur behandlung von amyloidogenen erkrankungen
NO20093464L (no) Nye medikamentblandinger basert pa anti-cholinergisk effektive forbindelser og beta-mimetika
PL372809A1 (en) Substituted 1,3-diphenylprop-2-en-1-one derivatives and preparation and uses thereof
EA200201271A1 (ru) Ингибиторы 11-бета-гидроксистероиддегидрогеназы типа 1
DE60120648D1 (de) Formulierungen von copolymer 1 (glatirameracetat) zur oralen, nasalen und pulmonalen verabreichung
BRPI0108395B8 (pt) derivados de pirrolopirimidinona, processos de preparação e uso
BR0210122A (pt) Composto ou um sal farmaceuticamente aceitável do mesmo, método para o tratamento ou prevenção de uma doença, uso do composto ou de seu sal, e, método para preparar o mesmo
EE200300033A (et) Tsüklopentanoindoolid, nende kasutamine ravimi valmistamiseks ning neid sisaldav farmatseutiline kompositsioon
ATE402929T1 (de) Pyrazinverbindungen als inhibitoren des transforming growth factor (tgf)
EA200300776A1 (ru) Производные фенэтаноламина для лечения респираторных заболеваний
NO20025450D0 (no) Ny farmasöytisk sammensetning
EA200501268A1 (ru) Ингибирующие вич 1,2,4-триазины
IL160171A0 (en) Depsipeptide derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
SE0102055D0 (sv) New Compounds
SE0102440D0 (sv) New compound
ATE332894T1 (de) Ein pyridin-n-oxid-derivat und ein prozess zu seiner umsetzung in pharmazeutische wirkstoffe
SE0002729D0 (sv) Novel compound form
DK1343472T3 (da) Thixotropisk næsespray
TNSN04034A1 (en) Combined preparations, containing 1,4-benzothiepine-1,1-dioxide derivatives and other active substances, and the use thereof
MEP39708A (en) New pharmaceutical compositions containing epinastine and pseudoephedrine
SE0000303D0 (sv) Novel compounds
ATE331523T1 (de) Statin-therapie zur verbesserung der aufrechterhaltung der kognitiven funktion
GEP20053512B (en) S-Methyl-Dihydro-Ziprasidone for Treatment of Psychiatric and Ocular Disorders.
BR0313175A (pt) Formulações farmacêuticas compreendendo combinações de epinastina, pseudoefedrina e metilefedrina
FR2809725B1 (fr) Propanolaminotetralines, leur preparation et compositions pharmaceutiques en contenant